Medicinal – Page 171

Moving beyond multi-triazole to multi-fungicide resistance: Broader selection of drug resistance in the human fungal pathogen Aspergillus fumigatus

mycolabadmin

Aspergillus fumigatus is a dangerous fungal infection treated with triazole drugs, but the fungus is developing resistance to multiple antifungal medications. This resistance appears to be selected in agricultural settings where fungicides are used on crops, and resistant strains then spread to humans through the air. The problem is worse because agricultural fungicides are selecting for strains resistant to multiple drug classes at once, making infections harder to treat. Addressing this issue requires reducing fungicide use in agriculture and better strategies for managing antifungal resistance.

Time- and temperature-dependent Pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples

mycolabadmin

This study investigated how stable Pentraxin 3 (Ptx3), a protein used to detect fungal infections, remains when stored at different temperatures. Researchers found that Ptx3 stays reliable for up to 8 months in freezer storage at −20°C and even longer at −80°C, making it a dependable biomarker for diagnosing serious fungal infections. However, storing samples at room temperature (37°C) causes the protein to break down quickly, so proper cold storage is essential for accurate test results.

Utility of MALDI-ToF MS for Recognition and Antifungal Susceptibility of Nannizzia, an Underestimated Group of Dermatophytes

mycolabadmin

Nannizzia species are soil-dwelling fungi that increasingly cause stubborn skin, nail, and hair infections in humans and animals. This study tested two laboratory methods for identifying these fungi and measured their sensitivity to eight antifungal drugs. The faster liquid-based method was slightly more accurate (67%) than the traditional culture method (62%), though neither method could identify six very rare species. Terbinafine emerged as the most effective antifungal treatment in laboratory tests.

Clinical insights into mixed Candida and bacterial bloodstream infections: a retrospective cohort study

mycolabadmin

This study found that when both Candida fungus and bacteria are present together in a patient’s bloodstream, the outcome is much more serious than when only Candida is present. Among patients with these mixed infections, over 60% died within 30 days compared to about 52% for those with only Candida. The research shows that giving the right antibiotics early and following proper treatment guidelines can significantly improve survival chances in these severe, life-threatening infections.

Nosocomial Diarrhea Distribution by Cryptosporidium in Isfahan

mycolabadmin

Researchers tested 217 patients who developed diarrhea in a hospital in Isfahan, Iran to see if a parasite called Cryptosporidium was responsible. Using advanced DNA testing, they found the parasite in only 2 out of 217 patients (less than 1%). This suggests that while this parasite can spread in hospitals, it is not a major cause of diarrhea in this particular hospital, which likely has good hygiene practices.

Morpho-phylogenetic evidence reveals novel species and new records of Torula (Torulaceae, Pleosporales) from medicinal plants in China

mycolabadmin

Researchers discovered two new species of fungi (Torula dispora and Torula strychnicola) living on medicinal plants in China. These fungi, which break down dead plant material, were identified using both physical characteristics and genetic analysis. The study also documented three additional species of Torula fungi on medicinal plants for the first time, suggesting that medicinal plants harbor greater fungal diversity than previously known.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

Isavuconazole is an antifungal medication used to treat serious fungal infections in people with weakened immune systems. This study reviewed and analyzed three clinical trials to compare how well isavuconazole works compared to other antifungal drugs. The results showed that isavuconazole is just as effective as other antifungals but has fewer side effects, particularly fewer problems with liver health and drug-related adverse events. This makes isavuconazole a good alternative choice for patients who cannot use other antifungal medications or who are at risk of liver damage.

New approaches to tackle a rising problem: Large-scale methods to study antifungal resistance

mycolabadmin

Fungal infections are becoming increasingly resistant to antifungal drugs, creating a serious public health challenge. Scientists are using advanced genetic sequencing and laboratory techniques to understand how fungi develop drug resistance and identify the specific genetic changes responsible. By cataloging resistance mutations and creating shared databases, researchers aim to develop better diagnostic tests and treatment strategies to combat these dangerous infections.

Rac1/PAK1 signaling contributes to bone cancer pain by regulation dendritic spine remodeling in rats

mycolabadmin

Researchers studied how bone cancer pain develops in rats and found that a specific cellular signaling pathway called Rac1/PAK1 plays a key role. When tumors grow in bone, this pathway becomes overactive and causes changes in nerve cell structures called dendritic spines, which leads to increased pain sensitivity. By blocking this pathway with a drug called NSC23766, scientists were able to reduce pain and reverse the harmful changes to nerve cells, suggesting a new potential treatment approach for cancer patients suffering from bone pain.

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

This study examined why some fungal nail infections caused by Candida albicans don’t respond to itraconazole treatment. Researchers found that resistant fungi have higher levels of genes that pump the antifungal drug out of their cells and genes that help them form protective biofilm layers. These findings suggest that combining itraconazole with drugs that block these pumps or disrupt biofilms could be more effective for treating stubborn fungal nail infections.

Research Topic: Medicinal